Team:Freiburg/main2

From 2013.igem.org

(Difference between revisions)
Line 30: Line 30:
height:50px;
height:50px;
float:left;
float:left;
 +
margin-top:50px;
 +
margin-left:20px;
 +
}
 +
 +
#epigenetic{
 +
height:50px;
 +
float:left;
 +
margin-top:60px;
 +
margin-left:10px;
}
}
Line 79: Line 88:
   <img id="cas" src="https://static.igem.org/mediawiki/2013/9/94/Freiburg_2013_main2_Cas.png">
   <img id="cas" src="https://static.igem.org/mediawiki/2013/9/94/Freiburg_2013_main2_Cas.png">
   <img id="activation" src="https://static.igem.org/mediawiki/2013/0/03/Freiburg_2013_main2_Activation.png">
   <img id="activation" src="https://static.igem.org/mediawiki/2013/0/03/Freiburg_2013_main2_Activation.png">
 +
  <img id="epigenetic"src="https://static.igem.org/mediawiki/2013/3/31/Freiburg_2013_main2_Epigenetic.png">
   <img id="klammer_gross" src="https://static.igem.org/mediawiki/2013/8/82/Freiburg_2013_main2_Rahmen_gross_rechts.png">
   <img id="klammer_gross" src="https://static.igem.org/mediawiki/2013/8/82/Freiburg_2013_main2_Rahmen_gross_rechts.png">
</td>
</td>

Revision as of 19:38, 26 September 2013


Abstract

Our Team developed a universal toolkit, termed uniCAS, that enables customizable gene regulation in mammalian cells. Therefore, we engineered the recently discovered and highly promising CRISPR/Cas9 system. The regulation is based on the RNA-guided Cas9 protein, which allows targeting of specific DNA sequences. Our toolkit comprises not only a standardized Cas9 protein, but also different effector domains for efficient gene activation or repression.